1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics, December 2016 (p40)

Biotechnology Analysis & Statistics, December 2016 (p40)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

1171-1200 of about 4200 reports

Purchase Reports From Reputable Market Research Publishers

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

  • Industries : Cancer, Pathology, Drug Discovery and Development
  • Countries : United States
Dental Biomaterials - Medical Devices Pipeline Assessment, 2016

Dental Biomaterials - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Dental Biomaterials - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Dental Biomaterials - Medical Devices Pipeline Assessment, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Medical Device, Biomaterial, Biomaterial, Healthcare, Advanced Material, Biotechnology
  • Countries : United States
Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, ...

  • Industries : Pathology, Healthcare, In Vitro Diagnostics, Medical Device
  • Countries : United States
Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : United States
Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2016

Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : United States
Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

  • Industries : Cancer, Pathology
  • Countries : United States
Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2016

Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : United States
Diabetes & Obesity Drug Development Pipeline Review, 2016

Diabetes & Obesity Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Diabetes & Obesity Drug Development Pipeline Review, 2016 Summary The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...

  • Industries : Pathology, Chronic Disease, Therapy
  • Countries : World
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline ...

  • Industries : Cancer, Pathology
  • Countries : United States
Myelodysplastic Syndrome - Pipeline Review, H2 2016

Myelodysplastic Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Myelodysplastic Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides ...

  • Industries : Cancer, Pathology
  • Countries : United States
Neuroblastoma - Pipeline Review, H2 2016

Neuroblastoma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Neuroblastoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States
Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2016

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Healthcare
  • Countries : United States
RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Pipeline Review, H2 2016

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘RAF Proto Oncogene Serine/Threonine Protein ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical
  • Countries : United States
Aplastic Anemia - Pipeline Review, H2 2016

Aplastic Anemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Aplastic Anemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology
  • Countries : United States
Hepatitis B - Pipeline Review, H2 2016

Hepatitis B - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Hepatitis B - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B - Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology, Healthcare
  • Countries : United States, World
Fanconi Anemia - Pipeline Review, H2 2016

Fanconi Anemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Fanconi Anemia - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Pathology
  • Countries : United States, World
Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Pipeline Review, H2 20

Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Pipeline Review, H2 20

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B o ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World
Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H2 2016

Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polyarticular Juvenile Idiopathic ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical, Biopharmaceutical
  • Countries : United States
Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H2 2016

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) - Pipeline Review, H2 2016

Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 o ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia ...

  • Industries : Cancer, Pathology
  • Countries : United States
RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) - Pipeline Review, H2 2016

RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World, United States
TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Pipeline Review, H2 2016

TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Pipeline Review, H2 2016’, provides in depth ...

  • Industries : Mental Health, Pathology, Drug Discovery and Development, Therapy
  • Countries : World, United States, Germany
Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Granulocyte Macrophage Colony Stimulating ...

  • Industries : Biological Therapy, Therapy, Biotechnology, Pathology
  • Countries : United States
Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2016

Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2016 ...

  • Industries : Therapy, Cancer, Pathology
  • Countries : United States, World
Sino Biopharmaceutical Ltd (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sino Biopharmaceutical Ltd (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Sino Biopharmaceutical Ltd (Sino) is a pharmaceutical company that develops, manufactures and markets Chinese medicines and chemical medicines. The company’s products include kaishi (alprostadil) ...

  • Industries : Pharmaceutical
Scarab Genomics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Scarab Genomics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Scarab Genomics LLC (Scarab Genomics) is a biotechnology company that developsbio-engineered materials. The company’s products include modified korz medium kit, modified korz medium with glucose ...

  • Industries : Genomics
Kythera Biopharmaceuticals Inc (KYTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kythera Biopharmaceuticals Inc (KYTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Kythera Biopharmaceuticals Inc (Kythera), a subsidiary of Allergan Plc is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medical aesthetics products. The ...

  • Industries : Biopharmaceutical
  • Countries : United States
Sinovac Biotech Ltd (SVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sinovac Biotech Ltd (SVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines to eliminate human diseases. The company’s products include healive, ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.